Hyperlipidemia [clinicaltrials_resource:9490da885133129bdcf857b6d77dfbe8]
Metabolism and Body Shape of Healthy Children and Children With Chronic Infections [clinicaltrials:NCT00001142]Evaluation of Lipoproteins [clinicaltrials:NCT00001168]Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome [clinicaltrials:NCT00004466]Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia [clinicaltrials:NCT00006493]Differential Metabolism of Dietary Fatty Acids [clinicaltrials:NCT00059254]Antihyperlipidemic Effects of Oyster Mushrooms [clinicaltrials:NCT00069524]Improving Medication Adherence in Comorbid Conditions [clinicaltrials:NCT00072891]clinicaltrials:NCT00090402A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) [clinicaltrials:NCT00093899]Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction [clinicaltrials:NCT00106236]Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes [clinicaltrials:NCT00108459]clinicaltrials:NCT00108485Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy [clinicaltrials:NCT00109603]The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose [clinicaltrials:NCT00114855]Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) [clinicaltrials:NCT00117494]Veterans Walk for Health Study [clinicaltrials:NCT00123435]Heart Disease on the Mend [clinicaltrials:NCT00127751]A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease [clinicaltrials:NCT00134173]Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia [clinicaltrials:NCT00134485]A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol [clinicaltrials:NCT00136942]Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. [clinicaltrials:NCT00136981]Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. [clinicaltrials:NCT00137462]A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol [clinicaltrials:NCT00138762]Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate [clinicaltrials:NCT00139061]Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels [clinicaltrials:NCT00143234]Stop Atherosclerosis in Native Diabetics Study [clinicaltrials:NCT00147251]Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics [clinicaltrials:NCT00157638]Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [clinicaltrials:NCT00160329]clinicaltrials:NCT00166166The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. [clinicaltrials:NCT00172419]Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. [clinicaltrials:NCT00174304]Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia [clinicaltrials:NCT00174330]Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients [clinicaltrials:NCT00184951]clinicaltrials:NCT00194428A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin [clinicaltrials:NCT00195793]Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) [clinicaltrials:NCT00200993]The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS [clinicaltrials:NCT00202241]clinicaltrials:NCT00203476Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) [clinicaltrials:NCT00211705]The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia [clinicaltrials:NCT00222833]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT01786421 [clinicaltrials_resource:10bd1f4147c148ac234be8bf162beafc]eligibility for clinicaltrials:NCT02135029 [clinicaltrials_resource:12448ba07fcbd42104b0648ec212c289]eligibility for clinicaltrials:NCT02315105 [clinicaltrials_resource:6ce484cb514950e9b0d7b4d9a2fd7217]eligibility for clinicaltrials:NCT00296400 [clinicaltrials_resource:8273ac6870bc6cc52dd8ce5e424ff901]eligibility for clinicaltrials:NCT01512940 [clinicaltrials_resource:877023e90ba08ade8cd8ddc6998e8a04]eligibility for clinicaltrials:NCT00586950 [clinicaltrials_resource:8dda460a995ff4c3e70af197a1a0b9e9]eligibility for clinicaltrials:NCT01077193 [clinicaltrials_resource:c0ea10bf42cea967747541fb5c7f37a1]eligibility for clinicaltrials:NCT00451464 [clinicaltrials_resource:ff1902557714f02e159440db094fee80]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01786421 [clinicaltrials_resource:10bd1f4147c148ac234be8bf162beafc]eligibility for clinicaltrials:NCT02135029 [clinicaltrials_resource:12448ba07fcbd42104b0648ec212c289]eligibility for clinicaltrials:NCT01234532 [clinicaltrials_resource:13f04109fdc44e6a3b903e8502066340]eligibility for clinicaltrials:NCT02315105 [clinicaltrials_resource:6ce484cb514950e9b0d7b4d9a2fd7217]eligibility for clinicaltrials:NCT00296400 [clinicaltrials_resource:8273ac6870bc6cc52dd8ce5e424ff901]eligibility for clinicaltrials:NCT01512940 [clinicaltrials_resource:877023e90ba08ade8cd8ddc6998e8a04]eligibility for clinicaltrials:NCT00586950 [clinicaltrials_resource:8dda460a995ff4c3e70af197a1a0b9e9]eligibility for clinicaltrials:NCT01077193 [clinicaltrials_resource:c0ea10bf42cea967747541fb5c7f37a1]eligibility for clinicaltrials:NCT00451464 [clinicaltrials_resource:ff1902557714f02e159440db094fee80]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Hyperlipidemia [clinicaltrials_resource:9490da885133129bdcf857b6d77dfbe8]
Bio2RDF identifier
9490da885133129bdcf857b6d77dfbe8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9490da885133129bdcf857b6d77dfbe8
identifier
clinicaltrials_resource:9490da885133129bdcf857b6d77dfbe8
title
Hyperlipidemia
@en
type
label
Hyperlipidemia [clinicaltrials_resource:9490da885133129bdcf857b6d77dfbe8]
@en